Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01889 (
ankylosing spondylitis
)
5,717
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Specific immunoreactive anti-
Klebsiella
antibodies are found in patients with
ankylosing spondylitis
(AS), a significant proportion of whom have occult inflammatory bowel disease. Molecular mimicry between
Klebsiella
or other bacterial antigens and HLA-B27 has been suggested in the pathogenesis of AS. The specificity of increased immunoreactivity against
Klebsiella
remains to be assessed against the abundant anaerobic bacterial flora, present either in healthy controls or in patients with ulcerative colitis (UC) and Crohn's disease (CD). Total immunoglobulin (Ig; IgG, IgA, IgM) immunoreactivity was measured by ELISA against
Klebsiella
pneumoniae, Proteus mirabilis, Escherichia coli and ten anaerobic isolates of the predominant normal bowel flora in 35 patients with active AS, 60 patients with inflammatory bowel disease (30 CD, 30 UC), 60 patients with active rheumatoid arthritis (RA) and 60 healthy controls. Ig immunoreactivity to K. pneumoniae was significantly elevated in AS (P < 0.001), CD (P < 0.001) and UC (P < 0.001) patients compared with RA patients and healthy controls. Furthermore, Ig immunoreactivity to P. mirabilis was significantly elevated only in RA patients, compared with the other inflammatory groups (P < 0.001) and controls (P < 0.001). There was no significant antibody response against E. coli or the ten obligate anaerobes in any of the test groups. The data suggested an increased immune response to
Klebsiella
in patients with AS, UC, CD and to Proteus in patients with RA. The specificity of these responses in some patients supported a possible role for enteric
Klebsiella
in the pathogenesis of AS and Proteus in RA. The role of
Klebsiella
in inflammatory bowel disease requires further study.
...
PMID:Antibody responses to gut bacteria in ankylosing spondylitis, rheumatoid arthritis, Crohn's disease and ulcerative colitis. 919 9
Enterobacteria, in particular
Klebsiella
spp., have been implicated in the aetiopathogenesis of
ankylosing spondylitis
. A comprehensive examination of the faecal flora of 82 patients with
ankylosing spondylitis
, either primary (67), or in association with inflammatory bowel disease (4), reactive arthritis (6) or psoriatic arthritis (5), was performed and compared with that of a control population (36) of healthy individuals. The range of flora identified was similar in both populations and there was no increased isolation rate of
Klebsiella
or other proposed arthritogenic organism in those with spondyloarthropathy. In those patients in whom
Klebsiella
was identified, its presence was not related to disease activity, the erythrocyte sedimentation rate or C-reactive protein.
...
PMID:Faecal flora in spondyloarthropathy. 929 53
IgM, IgG and IgA class antibodies against three
Klebsiella
pneumoniae capsular types, Escherichia coli and Proteus mirabilis, as well as total immunoglobulin concentrations, were measured by enzyme immunoassay and radial immunodiffusion technique, respectively, in paired serum and synovial fluid samples from eight patients with
ankylosing spondylitis
and 10 with rheumatoid arthritis. No clear evidence for intra-articular antibody production against any of the studied microbes was found.
...
PMID:IgM, IgG and IgA class enterobacterial antibodies in serum and synovial fluid in patients with ankylosing spondylitis and rheumatoid arthritis. 937 20
This study was carried out to characterize the antibody class response by ELISA to seven
Klebsiella
pneumoniae serotypes (K2, K3, K17, K21, K26, K36, K50) in five different groups, 40 HLA-B27-positive
ankylosing spondylitis
(AS) patients, 46 patients with Crohn's disease (CD), 38 patients with ulcerative colitis (UC), 50 patients with active anti-endomysial antibody-positive coeliac disease and 40 healthy controls, using whole bacteria and capsular polysaccharide. IgG antibody levels were significantly elevated in AS patients to K17, K36, K50; IgA to K2, K3, K21, K26, K36 and K50; and IgM to serotype K21 when compared to normal controls. Furthermore, IgG antibody levels were significantly elevated in CD patients to K2, K17, K21, K26, K36 and K50; IgA to K2, K3, K21, K26, K36 and K50; and IgM to K2, K3, K17, K21 and K50. Increased IgG antibody levels in the UC group were limited only to K17, K36 and K50. No antibody class was increased to any of the K. pneumoniae serotypes in the coeliac disease group. The immune responses in AS patients also involve
Klebsiella
bacteria having capsular serotypes other than K26, K36 and K50. The similarity in the immune responses between CD and AS groups suggests that many AS patients may have occult bowel inflammation.
...
PMID:Characterization of the humoral immune response to Klebsiella species in inflammatory bowel disease and ankylosing spondylitis. 1037 Dec 97
The etiopathogenesis of
ankylosing spondylitis
is still incompletely understood. HLA-B27 is important as more than 90% of the patients possess the antigen, but how this genetic marker confers disease susceptibility is yet to be understood. Recent studies of families and twins affected by
ankylosing spondylitis
have shown that additional non-HLA-B27 genes are necessary for disease development. The exogenous agent initiating chronic inflammation is yet to be identified, but
Klebsiella
pneumoniae remains a candidate. The microorganism may act through the intestinal canal as more than 60% of the patients exhibit inflammatory changes in the bowel.
...
PMID:[Pathogenesis of Bechterew disease]. 988 41
Klebsiella
is suggested to trigger
ankylosing spondylitis
(AS) and acute anterior uveitis (AAU) in HLA-B27-positive individuals. Previous investigations showed an increased antibody response to the
Klebsiella
capsular types K26, K36, and K50 in sera from HLA-B27-positive AS patients. In the present study the prevalence and titers of antibodies against
Klebsiella
capsular antigens were measured by means of an ELISA in 32 sera from HLA-B27-positive AAU patients either with (n = 10) or without AS (n = 22) and compared with sera from HLA-B27-negative AS-patients (n = 13). Sera from either HLA-B27-positive (n = 45) or negative (n = 40) healthy individuals served as control. Sera from HLA-B27-positive AAU with or without AS showed significantly higher antibody prevalence and IgG-titers against capsular antigens of the
Klebsiella
serotypes K26, K36, and K50 when compared with sera from HLA-B27-negative AS patients or with healthy controls. These results might be taken to indicate the predominance of these serotypes in the HLA-B27-associated AS and AAU.
...
PMID:Humoral immune response to Klebsiella capsular polysaccharides in HLA-B27-positive patients with acute anterior uveitis and ankylosing spondylitis. 989 2
The role of microbial lipopolysaccharides (LPS) in the aetiopathogenesis of
ankylosing spondylitis
(AS) is a matter of continuing debate. In this study, class-specific IgG, IgA and IgM antibodies against
Klebsiella
pneumoniae, Escherichia coli, Salmonella typhimurium and Salmonella enteritidis LPS were measured by enzyme-linked immunosorbent assay (ELISA) in 100 AS patients, 50 rheumatoid arthritis (RA) patients and 50 healthy control subjects. The AS patients had significantly elevated levels of IgG and IgA antibodies against K. pneumoniae LPS (P < 0.001) and IgA antibodies against E. coli LPS (P < 0.05) compared to healthy controls. There were no significant elevations of antibody levels against S. typhimurium and S. enteritidis in the three study groups. In addition, there was a correlation between IgG and IgA anti-K. pneumoniae LPS antibody levels and the acute-phase reactant C-reactive protein (P < 0.001).
...
PMID:Antibodies to Klebsiella pneumoniae lipopolysaccharide in patients with ankylosing spondylitis. 997 59
The purpose of the present study was to find out whether patients with
ankylosing spondylitis
(AS) carry fecal
Klebsiella
strains that belong to serotypes or species specific for AS. Somatic serotypes (O groups), capsular (K) serotypes, and biochemically identified species were determined for fecal klebsiellae isolated from 187 AS patients and 195 control patients. The controls were patients with fibromyalgia or rheumatoid arthritis. The 638 isolates of
Klebsiella
that were obtained represented 161 strains; 81 from AS patients and 80 from the controls. The average number of
Klebsiella
strains per patient was 1.7 for the AS group and 1.5 for the control group. The most common O group was O1, which was observed for isolates from 23 of 187 AS patients and 24 of 195 control patients. Next in frequency was group O2, which was observed for isolates from 17 AS patients and 15 control patients. Regarding the K serotypes, 59 different types were identified, revealing a heterogeneous representation of
Klebsiella
strains, without a predominance of any serotype. By biochemical identification,
Klebsiella
pneumoniae was the most frequently occurring species, being found in 45 AS patients and 45 control patients. Next in the frequency was K. oxytoca, which was observed in 26 AS patients and in 29 control patients. K. planticola and K. terrigena occurred in only a minority of patients. Altogether, when analyzed either separately or simultaneously according to O groups, K serotypes, and biochemically identified species, no evidence of the existence of AS-specific
Klebsiella
strains was obtained. These findings do not indicate participation of
Klebsiella
in the etiopathogenesis of AS.
...
PMID:Somatic serogroups, capsular types, and species of fecal Klebsiella in patients with ankylosing spondylitis. 1044 57
Structural and functional homology between bacterial proteins and host antigens, called molecular mimicry, is considered as significant pathogenic factor involved in several autoimmune diseases. The most important examples of this phenomenon reviewed in this work, involve rheumatic fever, Graves' disease,
ankylosing spondylitis
, Reiter's syndrome and rheumatic arthritis caused by infections with Streptococcus, Yersinia,
Klebsiella
, Escherichia coli, respectively.
...
PMID:[Molecular mimicry of bacteria as a factor in bacterial pathogenicity]. 1054 58
It has been well established that many diseases are linked to HLA antigens. Two of the most interesting HLA associations may provide some insight into the pathogenesis of rheumatic inflammatory conditions. In
ankylosing spondylitis
(AS), 96% of patients possess HLA-B27, whilst the frequency of this marker in the general population is c. 8%. In rheumatoid arthritis (RA), >90% of patients possess either HLA-DR1 or some subtypes of HLA-DR4, whilst the frequency of this marker in the general population is c. 35%. The association between HLA-B27 and reactive arthritis (ReA) has also been well established. Furthermore, it has been shown that ReA is triggered by infection via the gastrointestinal tract due to Yersinia, Salmonella or Campylobacter spp. and in the genitourinary tract due to chlamydia. In a similar way, microbiological and immunological studies have revealed an association between
Klebsiella
pneumoniae in AS and Proteus mirabilis in RA. This article reviews the possible pathological implications of the associations between HLA-B27, K. pneumoniae and AS, as well as HLA-DR1/DR4, P. mirabilis and RA.
...
PMID:HLA molecules, bacteria and autoimmunity. 1075 23
<< Previous
1
2
3
4
5
6
7
8
9
10